Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001209191-23-016458

Options or other derivatives

  • CHIEF OPERATING OFFICER acquired 64,915 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Jacobson Mark L. CHIEF OPERATING OFFICER 2023-03-02 Grant or award · Employee Stock Option (Right to Buy) +41,424 41,424 D
Jacobson Mark L. CHIEF OPERATING OFFICER 2023-03-02 Grant or award · Restricted Stock Units +23,491 23,491 D
Loading xslF345X03/doc4.xml…